Pharmaceuticals, Biotechnology and Life Sciences
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has launched a generic version of Tarceva®1(erlotinib) tablets, 100 and 150 mg, in the U.S.
Due to an increase in the incidence of medical ailments, the marketstudied is expected to grow over the forecast period.
The global food enzymes market is expected to grow at a CAGR of 7.5%from 2019 to reach $3,125.1 million by 2024 from $2,176.9 million in2019.
Takeda sells Xiidra to Novartis for up to$5.3 billion, TachoSil to Ethicon for approximately $400 million
Revenues of $4.3 billion GAAP diluted loss per share of $0.10 Non-GAAP diluted EPS of $0.60 Free cash flow of…
DUBLIN–(BUSINESS WIRE)–The “Smoothened Homolog (Protein Gx or SMO) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Hypoglycemia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. Alzheimer’s disease…
DUBLIN–(BUSINESS WIRE)–The “Post-Operative Pain – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
DUBLIN–(BUSINESS WIRE)–The “Global Erectile Dysfunction (ED) Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The erectile dysfunction (ED)…